{"id":"https://openalex.org/W1978126044","doi":"https://doi.org/10.1177/00912709922008164","title":"First Time in Human for GV196771: Interspecies Scaling Applied on Dose Selection","display_name":"First Time in Human for GV196771: Interspecies Scaling Applied on Dose Selection","alternate_titles":[],"publication_year":1999,"publication_date":"1999-06-01","ids":{"openalex":"https://openalex.org/W1978126044","doi":"https://doi.org/10.1177/00912709922008164","mag":"1978126044","pmid":"https://pubmed.ncbi.nlm.nih.gov/10354959"},"language":"en","primary_location":{"id":"doi:10.1177/00912709922008164","doi":"https://doi.org/10.1177/00912709922008164","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912709922008164","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978126044"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016023608","display_name":"Laura Iavarone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Iavarone","raw_affiliation_strings":["Department of Pharmacokinetics and Drug Metabolism, Glaxo Wellcome SpA, Medicines Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics and Drug Metabolism, Glaxo Wellcome SpA, Medicines Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037359475","display_name":"John F. Hoke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. F. Hoke","raw_affiliation_strings":["Clinical Pharmacology, Glaxo Wellcome, Greenford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Glaxo Wellcome, Greenford, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028458861","display_name":"Marco Bottacini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Bottacini","raw_affiliation_strings":["Department of Pharmacokinetics and Drug Metabolism, Glaxo Wellcome SpA, Medicines Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics and Drug Metabolism, Glaxo Wellcome SpA, Medicines Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041116856","display_name":"Robert J. Barnaby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Barnaby","raw_affiliation_strings":["Department of Pharmacokinetics and Drug Metabolism, Glaxo Wellcome SpA, Medicines Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics and Drug Metabolism, Glaxo Wellcome SpA, Medicines Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103520340","display_name":"G. C. Preston","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. C. Preston","raw_affiliation_strings":["Clinical Pharmacology, Glaxo Wellcome, Greenford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Glaxo Wellcome, Greenford, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5037359475"],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":2.1147,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.85262298,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"39","issue":"6","first_page":"560","last_page":"566"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.6636000275611877,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.6636000275611877,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.17309999465942383,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.09030000120401382,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interspecies-scaling","display_name":"interspecies scaling","score":0.7979999780654907},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.7260000109672546},{"id":"https://openalex.org/keywords/first-in-human-study","display_name":"first-in-human study","score":0.7379999756813049},{"id":"https://openalex.org/keywords/glycine-antagonist","display_name":"glycine antagonist","score":0.8830000162124634},{"id":"https://openalex.org/keywords/allometric-scaling","display_name":"allometric scaling","score":0.9850000143051147},{"id":"https://openalex.org/keywords/protein-binding","display_name":"protein binding","score":0.6449999809265137},{"id":"https://openalex.org/keywords/pharmacokinetic-simulation","display_name":"pharmacokinetic simulation","score":0.703000009059906},{"id":"https://openalex.org/keywords/compartmental-modeling","display_name":"compartmental modeling","score":0.9649999737739563},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.5370000004768372},{"id":"https://openalex.org/keywords/plasma-concentration-profiles","display_name":"plasma concentration profiles","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6659553647041321},{"id":"https://openalex.org/C153026981","wikidata":"https://www.wikidata.org/wiki/Q519888","display_name":"Allometry","level":2,"score":0.6090396642684937},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.5775070190429688},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5587281584739685},{"id":"https://openalex.org/C99844830","wikidata":"https://www.wikidata.org/wiki/Q102441924","display_name":"Scaling","level":2,"score":0.5206669569015503},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4458322823047638},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3691285252571106},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32987135648727417},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.32251954078674316},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24469774961471558},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2223038673400879},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.2098391354084015},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.08568474650382996},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009929","descriptor_name":"Organ Size","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018684","descriptor_name":"Glycine Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/00912709922008164","doi":"https://doi.org/10.1177/00912709922008164","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912709922008164","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:10354959","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10354959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1965927171","https://openalex.org/W1989927329","https://openalex.org/W1996889391","https://openalex.org/W2016812290","https://openalex.org/W2025262952","https://openalex.org/W2041349258","https://openalex.org/W2042099048","https://openalex.org/W2042835412","https://openalex.org/W2065457233","https://openalex.org/W2084691406","https://openalex.org/W2100130143","https://openalex.org/W2112689989","https://openalex.org/W2114333459","https://openalex.org/W2160876442","https://openalex.org/W2168235332","https://openalex.org/W2326035656","https://openalex.org/W4231660253","https://openalex.org/W7070742394"],"related_works":["https://openalex.org/W2077955587","https://openalex.org/W2007205652","https://openalex.org/W2943317238","https://openalex.org/W2114630402","https://openalex.org/W1970593964","https://openalex.org/W1977059612","https://openalex.org/W2084691406","https://openalex.org/W4239932015","https://openalex.org/W2024938615","https://openalex.org/W2025262952"],"abstract_inverted_index":{"The":[0,13,39],"utility":[1],"of":[2,36,50,59,126,134],"interspecies":[3,37],"scaling":[4,56],"in":[5,52,64,75,105,149],"early":[6],"drug":[7],"development":[8],"has":[9],"been":[10],"extensively":[11,94],"debated.":[12],"authors":[14],"discuss":[15,131],"the":[16,106,109,123,132,135,144,150],"dose":[17,41,137],"selection":[18,42,138],"strategy":[19,43,139],"for":[20,28,79,122,140],"a":[21,30,81],"first":[22,69],"time":[23],"into":[24],"man":[25],"(FTIM)":[26],"study":[27],"GV196771,":[29],"new":[31],"glycine":[32,82],"antagonist,":[33],"using":[34,54],"techniques":[35,67],"scaling.":[38,107],"FTIM":[40,151],"was":[44,115],"based":[45],"on":[46],"predicted":[47],"plasma":[48],"profiles":[49,121,147],"GV196771":[51,90,141],"humans":[53,76],"allometric":[55],"and":[57,61,77,91],"considerations":[58],"safety":[60],"pharmacological":[62],"activity":[63],"animals.":[65],"Allometric":[66],"were":[68,103],"retrospectively":[70],"applied":[71],"to":[72,88,117,143],"data":[73],"obtained":[74],"animals":[78],"GV150526,":[80],"antagonist":[83],"with":[84],"similar":[85],"pharmacokinetic":[86,111],"characteristics":[87],"GV196771.":[89,127],"GV150526":[92],"are":[93],"protein":[95,98],"bound;":[96],"thus,":[97],"binding":[99],"differences":[100],"among":[101],"species":[102],"considered":[104],"Using":[108],"scaled":[110],"parameters,":[112],"compartmental":[113],"modeling":[114],"performed":[116],"prospectively":[118],"simulate":[119],"concentration":[120,146],"oral":[124],"administration":[125],"This":[128],"article":[129],"will":[130],"outcome":[133],"prospective":[136],"compared":[142],"actual":[145],"observed":[148],"study.":[152]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978126044","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
